EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC-ND 4.0

Determination of remifentanil in neonatal dried blood spots by liquid chromatography-tandem mass spectrometry

Jurij Trontelj, Aleš Rozman, Aleš Mrhar

Acta Pharmaceutica · 2024

DOI: 10.2478/acph-2024-0010 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Acta Pharmaceutica, 2024. Verfasst von Jurij Trontelj und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1University of Ljubljana, Faculty of Pharmacy 1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Remifentanil, Tandem Mass Spectrometry, Dried Blood Spot Testing, Analgesics, Opioid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Remifentanil is an ultra-short-acting synthetic opioid-class analgesic which might be increasingly used “off-label” as pain management during labour. Side effects in parturients during labour, and in the infant at birth are of particular concern, especially respiratory depression which is concentration-dependent, and can occur at levels as low as 3–5 ng mL –1 . The safety of such use, particularly in newborns due to remifentanil placental transfer, has not been fully demonstrated yet, partly due to the lack of a suitable non-invasive analytical method. The aim of our work was to develop a sensitive method to monitor the levels of remifentanil in neonates by a non-invasive sampling of umbi lical cord blood to support efficacy and safety trials. The presented LC-MS method is sensitive enough to reliably quantify remifentanil in just 20 µL of blood at only 0.3 ng mL –1 . The dried blood spot sample preparation included solvent extraction with subsequent solid-phase extraction. The method was validated in terms of accuracy, precision, recovery, matrix effect, and stability, and was successfully applied to a small pilot study. The estimated arterial blood concentrations at the time of delivery ranged from 0.2 to 0.3, and up to 0.9 ng mL –1 in neonatal, and maternal samples, respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RemifentanilTandem Mass SpectrometryDried Blood Spot TestingAnalgesics, OpioidFetal BloodHumansInfant, NewbornFemaleChromatography, LiquidPregnancyPiperidinesPilot ProjectsReproducibility of ResultsSolid Phase Extraction

Stichwörter der Autor:innen

dried blood spotslabourpatient-controlled analgesiaremifentanilumbilical cord blood

Substanzen

RemifentanilAnalgesics, OpioidPiperidines

Autor:innen und Institutionen

  • 1University of Ljubljana, Faculty of Pharmacy 1000 Ljubljana, Slovenia.
  • 2Gynecology and Obstetrics Hospital Kranj, 4000 Kranj Slovenia.

Zitieren

APA

Trontelj, J., Rozman, A., & Mrhar, A. (2024). Determination of remifentanil in neonatal dried blood spots by liquid chromatography-tandem mass spectrometry. Acta Pharmaceutica. https://doi.org/10.2478/acph-2024-0010

Vancouver

Trontelj J, Rozman A, Mrhar A. Determination of remifentanil in neonatal dried blood spots by liquid chromatography-tandem mass spectrometry. Acta Pharmaceutica. 2024. doi:10.2478/acph-2024-0010

BibTeX
@article{Trontelj2024,
  author = {Trontelj, Jurij and Rozman, Aleš and Mrhar, Aleš},
  title = {Determination of remifentanil in neonatal dried blood spots by liquid chromatography-tandem mass spectrometry},
  journal = {Acta Pharmaceutica},
  year = {2024},
  doi = {10.2478/acph-2024-0010}
}
Kostenlos starten →